Ontario has released the February 2016 Summary of Changes document, which includes the addition of Hospira’s Inflectra at a price ... Read More
Events
17
Feb2016
17
Feb2016
Suzanne McGurn, the Executive Officer of the Ontario Public Drug Programs, issued a statement on behalf of the Pan Canadian ... Read More
12
Feb2016
The Alberta Price Confirmation (APC) is issued prior to an Alberta Drug Benefit List (ADBL) publication. The APC is a ... Read More
12
Feb2016
As part of the National Prescription Drug Utilization Information System (NPDUIS), the Patented Medicine Prices Review Board (PMPRB) has recently ... Read More
12
Feb2016
Modifications to the Procedure for Filing a Drug Submission Application for Generic Drugs with INESSS
/ INESSS, pCPA, Quebec, What's New
Since Québec is now participating in the pan-Canadian Pharmaceutical Alliance (pCPA), INESSS recently communicated that information sharing has now become ... Read More
02
Feb2016
New Pilot Initiative: Increasing Opportunities for Clinical Input and Feedback in CADTH pan-Canadian Oncology Drug Review Process
/ CADTH, pCODR, What's New
In November 2015, CADTH received stakeholder feedback on proposed changes to the pan-Canadian Oncology Drug Review (pCODR) program that would ... Read More
20
Jan2016
Order your subscription today to gain instant online access!
The C-MAP™ Canadian Drug Benefit Plans Reference Guide is the authoritative source ... Read More
21
Dec2015
The Patented Medicines Prices Review Board (PMPRB) has released their highly anticipated Strategic Plan 2015-2018. The PMPRB’s three-year strategic ... Read More